(Health-NewsWire.Net, January 13, 2017 ) The Ophthalmics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter ophthalmics partnering deals. The majority of deals are discovery, preclinical or development stage whereby the licensee obtains a right or an option right to license the licensors ophthalmics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest ophthalmics deals and contracts announced in the healthcare sectors.
The initial chapters of this report provide an orientation of ophthalmics dealmaking and business activities.
Chapter 1 provides an introduction to the report. Chapter 2 provides an overview of the trends in ophthalmics dealmaking since 2009 covering trends by year, deal type, stage of development, technology type and therapeutic indication. In addition the chapter includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. Analysis includes median values and distribution of values for each stage of development. Chapter 3 provides a review of the leading ophthalmics deals since 2009 listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=170889 Chapters 4 and 5 provide a comprehensive listing of the top 50 big pharma and big biotech companies with a brief summary followed by a comprehensive listing of ophthalmics deals, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. Ophthalmics Partnering Terms and Agreements provides the reader with the following key benefits: In-depth understanding of ophthalmics deal trends since 2009 Access ophthalmics deal headline, upfront, milestone and royalty data Research hundreds of actual contracts between ophthalmics partner companies Comprehensive access to over 400 links to actual ophthalmics deals entered into by the world’s biopharma companies Report scope Ophthalmics Partnering Terms and Agreements is intended to provide the reader with an in-depth understanding and access to ophthalmics trends and structure of deals entered into by leading companies worldwide. OphthalmicsPartnering Terms and Agreements includes:
Trends in ophthalmics dealmaking in the biopharma industry since 2009 Analysis of ophthalmics deal structure Access to headline, upfront, milestone and royalty data Access to hundreds of ophthalmics deal contract documents Comprehensive access to over 400 ophthalmics deal records The leading ophthalmics deals by value since 2009 Most active ophthalmics dealmakers since 2009 In Opthalmics Partnering Terms and Agreements, available deals and contracts are listed by:
Headline value and opfront payment value Royalty rate value Stage of development at signing
Deal component type Technology type Specific therapy indication
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=170889
Fuego Co.
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com
|